Rakovina Therapeutics Announces Stock Option Grants

DOWNLOAD VANCOUVER, BC, July 29, 2025 – Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery, is...